國立虎尾科技大學 |

Endometriosis and Adenomyosis = Global Perspectives Across the Lifespan /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Endometriosis and Adenomyosis/ edited by Engin Oral.
其他題名:	Global Perspectives Across the Lifespan /
其他作者:	Oral, Engin.
面頁冊數:	XXIV, 611 p. 89 illus., 73 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Gynecology. -
電子資源:	https://doi.org/10.1007/978-3-030-97236-3
ISBN:	9783030972363

Endometriosis and Adenomyosis = Global Perspectives Across the Lifespan /
Endometriosis and AdenomyosisGlobal Perspectives Across the Lifespan /[electronic resource] :edited by Engin Oral. - 1st ed. 2022. - XXIV, 611 p. 89 illus., 73 illus. in color.online resource.

Part I. Endometriosis: An Overview -- Endometriosis in Human History -- Global Epidemiologic Data on Endometriosis -- Presumptive Causes of Endometriosis across the Lifespan -- Pathogenesis of Endometriosis: Retrograde Menstruation and Metaplasia, Inflammation, Autoimmunity, Genetics -- Classification and Clinical Staging of Endometriosis -- Diagnostic Modalities: Imaging and Markers -- Multidisciplinary Aspects of Chronic Pain without Endometriosis -- Part II. Endometriosis across the Lifespan -- Endometriosis In Utero and Early Life -- Endometriosis in Adolescence -- Endometriosis in the Reproductive Years: Fertility and Pain -- Endometriosis in Peri- and Postmenopausal Years -- Pregnancy and Obstetric Outcomes -- Part III. Miscellaneous Clinical Presentations and Management of Endometriosis -- Recurrent Endometriosis -- A Rare Entity of Extra Pelvic Endometriosis: Scar, Diaphragmatic, Pulmonary Involvement -- Fertility Preservation for Endometriosis -- Malignancy Risks Associated with Endometriosis -- Psychological Considerations in Endometriosis -- Sexual Dysfunction and Endometriosis -- Nutritional Interventions, Complementary and Alternative Medicine for Endometriosis -- Prevention of Endometriosis: Is It Possible?- How to Establish a “Center of Excellence” for Endometriosis -- Cost Estimates Associated with Diagnosis and Treatment of Endometriosis -- Part IV. Adenomyosis: An Overview -- What Is Adenomyosis?- Adenomyosis in Medicine -- Insights into Adenomyosis Development -- Classification and Staging of Adenomyosis -- Non-invasive Diagnosis of Adenomyosis: Ultrasonography and MRI -- Part V: Adenomyosis across the Lifespan -- Adenomyosis in Adolescence -- Adenomyosis in the Reproductive Years: Abnormal Uterine Bleeding, Pain, Fertility -- Pregnancy and Obstetric Outcomes in Adenomyosis -- Does Adenomyosis Increase Cancer Risk?- Part VI. Clinical Pharmaceutical Features of Drugs Used in Endometriosis and Adenomyosis Treatment -- Hormonal Therapy: Oral Contraceptives, Progestins, Danazol, Aromatase Inhibitors -- GnRH Agonists and Antagonists -- Part VII. Guidelines and Future Prospects for Endometriosis and Adenomyosis -- Recent Guidelines on Endometriosis and Adenomyosis -- The Future of Endometriosis and Adenomyosis Research.

Although endometriosis and adenomyosis are often assessed under the same umbrella, the epidemiology, clinical manifestations and management strategies of endometriosis and adenomyosis occur differently during the life cycle of a woman. Endometriosis can be diagnosed at many points across the lifespan, including adolescence and the climacterium, as well as pregnancy. Being associated with potential adverse health effects, different clinical presentations requiring different therapeutic approaches render it imperative to tailor management strategies for each period of the lifespan: in utero and early life, puberty and adolescence, reproductive years, pregnancy, late reproductive age, and the menopause. This book provides comprehensive insight into the general aspects, diagnosis and treatment modalities of endometriosis and adenomyosis in all stages of a woman’s life - a unique element of its approach. Thematic sections discuss the basics of diagnosis and management of both endometriosis and adenomyosis from birth through menopause, including aspects of fertility preservation, sexual dysfunction, psychological considerations and prevention. The current pharmaceutical approaches and efficacy are presented, including progestins, aromatase inhibitors and GnRH agonists and antagonists. The final section provides current practice guidelines for the management of both conditions as well as an investigation into future research and clinical strategies. Taking a truly global perspective, Endometriosis and Adenomyosis will be a valuable resource for reproductive endocrinologists, infertility specialists and obstetricians and gynecologists worldwide. .

ISBN: 9783030972363

Standard No.: 10.1007/978-3-030-97236-3doiSubjects--Topical Terms:

644094
Gynecology.

LC Class. No.: R1

Dewey Class. No.: 613.9

Endometriosis and Adenomyosis = Global Perspectives Across the Lifespan /
LDR:05287nam a22003975i 4500 001 1086565
003 DE-He213
005 20220524152739.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030972363 $9 978-3-030-97236-3
024 7 $a 10.1007/978-3-030-97236-3 $2 doi
035 $a 978-3-030-97236-3
050 4 $a R1
072 7 $a MFKC $2 bicssc
072 7 $a HEA039060 $2 bisacsh
072 7 $a MFKC $2 thema
082 0 4 $a 613.9 $2 23
245 1 0 $a Endometriosis and Adenomyosis $h [electronic resource] : $b Global Perspectives Across the Lifespan / $c edited by Engin Oral.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XXIV, 611 p. 89 illus., 73 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Part I. Endometriosis: An Overview -- Endometriosis in Human History -- Global Epidemiologic Data on Endometriosis -- Presumptive Causes of Endometriosis across the Lifespan -- Pathogenesis of Endometriosis: Retrograde Menstruation and Metaplasia, Inflammation, Autoimmunity, Genetics -- Classification and Clinical Staging of Endometriosis -- Diagnostic Modalities: Imaging and Markers -- Multidisciplinary Aspects of Chronic Pain without Endometriosis -- Part II. Endometriosis across the Lifespan -- Endometriosis In Utero and Early Life -- Endometriosis in Adolescence -- Endometriosis in the Reproductive Years: Fertility and Pain -- Endometriosis in Peri- and Postmenopausal Years -- Pregnancy and Obstetric Outcomes -- Part III. Miscellaneous Clinical Presentations and Management of Endometriosis -- Recurrent Endometriosis -- A Rare Entity of Extra Pelvic Endometriosis: Scar, Diaphragmatic, Pulmonary Involvement -- Fertility Preservation for Endometriosis -- Malignancy Risks Associated with Endometriosis -- Psychological Considerations in Endometriosis -- Sexual Dysfunction and Endometriosis -- Nutritional Interventions, Complementary and Alternative Medicine for Endometriosis -- Prevention of Endometriosis: Is It Possible?- How to Establish a “Center of Excellence” for Endometriosis -- Cost Estimates Associated with Diagnosis and Treatment of Endometriosis -- Part IV. Adenomyosis: An Overview -- What Is Adenomyosis?- Adenomyosis in Medicine -- Insights into Adenomyosis Development -- Classification and Staging of Adenomyosis -- Non-invasive Diagnosis of Adenomyosis: Ultrasonography and MRI -- Part V: Adenomyosis across the Lifespan -- Adenomyosis in Adolescence -- Adenomyosis in the Reproductive Years: Abnormal Uterine Bleeding, Pain, Fertility -- Pregnancy and Obstetric Outcomes in Adenomyosis -- Does Adenomyosis Increase Cancer Risk?- Part VI. Clinical Pharmaceutical Features of Drugs Used in Endometriosis and Adenomyosis Treatment -- Hormonal Therapy: Oral Contraceptives, Progestins, Danazol, Aromatase Inhibitors -- GnRH Agonists and Antagonists -- Part VII. Guidelines and Future Prospects for Endometriosis and Adenomyosis -- Recent Guidelines on Endometriosis and Adenomyosis -- The Future of Endometriosis and Adenomyosis Research.
520 $a Although endometriosis and adenomyosis are often assessed under the same umbrella, the epidemiology, clinical manifestations and management strategies of endometriosis and adenomyosis occur differently during the life cycle of a woman. Endometriosis can be diagnosed at many points across the lifespan, including adolescence and the climacterium, as well as pregnancy. Being associated with potential adverse health effects, different clinical presentations requiring different therapeutic approaches render it imperative to tailor management strategies for each period of the lifespan: in utero and early life, puberty and adolescence, reproductive years, pregnancy, late reproductive age, and the menopause. This book provides comprehensive insight into the general aspects, diagnosis and treatment modalities of endometriosis and adenomyosis in all stages of a woman’s life - a unique element of its approach. Thematic sections discuss the basics of diagnosis and management of both endometriosis and adenomyosis from birth through menopause, including aspects of fertility preservation, sexual dysfunction, psychological considerations and prevention. The current pharmaceutical approaches and efficacy are presented, including progestins, aromatase inhibitors and GnRH agonists and antagonists. The final section provides current practice guidelines for the management of both conditions as well as an investigation into future research and clinical strategies. Taking a truly global perspective, Endometriosis and Adenomyosis will be a valuable resource for reproductive endocrinologists, infertility specialists and obstetricians and gynecologists worldwide. .
650 2 4 $a Gynecology. $3 644094
650 1 4 $a Reproductive Medicine. $3 669081
650 0 $a Gynecology . $3 1253939
650 0 $a Reproductive health. $3 798422
700 1 $a Oral, Engin. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1393381
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030972356
776 0 8 $i Printed edition: $z 9783030972370
776 0 8 $i Printed edition: $z 9783030972387
856 4 0 $u https://doi.org/10.1007/978-3-030-97236-3
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)